Jitendra Mohan sold $1.9M of ALAB
Chief Executive Officer at Astera Labs, Inc.. 18,264 shares at an average of $101.52, traded Jul 9, 2025, filed Jul 11, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.9M at market
- 0Share of holdings soldSold 0.4% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-25-000078, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By Living Trust10b5-1 | -1,162 | $100.01 | $116k | 4,341,058 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,164 | $100.01 | $116k | 761,046 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 110b5-1 | -1,164 | $100.01 | $116k | 761,053 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 210b5-1 | -1,164 | $100.01 | $116k | 761,053 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 110b5-1 | -1,164 | $100.01 | $116k | 511,054 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 210b5-1 | -1,164 | $100.01 | $116k | 511,054 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By Living Trust10b5-1 | -1,882 | $102.46 | $193k | 4,339,176 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,880 | $102.46 | $193k | 759,166 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 110b5-1 | -1,880 | $102.46 | $193k | 759,173 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 210b5-1 | -1,880 | $102.46 | $193k | 759,173 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 110b5-1 | -1,880 | $102.46 | $193k | 509,174 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 210b5-1 | -1,880 | $102.46 | $193k | 509,174 | Jul 11, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $25M 150,000 shares | -9% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $5.5M 33,000 shares | -9% | |
| 25Weak | Astera Labs, Inc. | Jack R Lazar director | $374k 2,500 shares | -3% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $1.7M 11,430 shares | -6% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $13M 90,459 shares | -4% | |
| 50Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $668k 4,620 shares | -3% | |
| 60Notable | Astera Labs, Inc. | Sanjay Gajendra President and COO | $13M 90,459 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.